Role of gadoxetic acid-enhanced liver magnetic resonance imaging in the evaluation of hepatocellular carcinoma after locoregional treatment

doi:10.3748/wjg.v28.i26.3116

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 28, Issue 26

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4687)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-11) series.

Item

Count

PDF

299

WORD

HTML

2453

Figures (1-11)

484

Sum=3286

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

406

Download

995

Sum=1401

Jul 14, 2022 (publication date) through Nov 19, 2024

Times Cited of This Article

Times Cited (6)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Gastroenterol. Jul 14, 2022; 28(26): 3116-3131
Published online Jul 14, 2022. doi: 10.3748/wjg.v28.i26.3116

Full Size Figure Download Figure

Figure 4 A 62-yr-old male with typical hepatocellular carcinoma in segment IVa who underwent trans-arterial chemoembolization with microparticles (Lifepearl 100 +/- 25 microns) preloaded with 50 mg of Farmorubicin and later with non-loadable Hydropearl 400 +/- 75 microns microparticles. A: Pre-treatment computed tomography (CT) images: arterial phase; B: Pre-treatment CT images: portal phase; C: Pre-treatment CT images: delayed phase; D: Pre-trans-arterial chemoembolization (TACE) angiographic image; E: Post-TACE angiographic image; F: Post-TACE cone beam CT.

Citation: Gatti M, Maino C, Darvizeh F, Serafini A, Tricarico E, Guarneri A, Inchingolo R, Ippolito D, Ricardi U, Fonio P, Faletti R. Role of gadoxetic acid-enhanced liver magnetic resonance imaging in the evaluation of hepatocellular carcinoma after locoregional treatment. World J Gastroenterol 2022; 28(26): 3116-3131
URL: https://www.wjgnet.com/1007-9327/full/v28/i26/3116.htm
DOI: https://dx.doi.org/10.3748/wjg.v28.i26.3116